The Competence Network Malignant Lymphomas (KML), founded in 1999 at the initiative of the Federal Ministry of Education and Research (BMBF), brings together interdisciplinary medical and scientific expertise in research on malignant lymphomas. The network helps to release synergies in evidence-based clinical research and contributes to the accelerated transfer of advances in knowledge gained from therapeutic studies for the health care of lymphoma patients.
During the regular BMBF funding period (1999–2009) individual subprojects were hived off, such as the Cochrane Haematological Malignancies Group (CHMG) or the Scientific Institute of Haematologists and Oncologists in Private Practice (WINHO GmbH). At the end of BMBF funding, pivotal KML projects such as the reference diagnostic panel for KML lymphoma study groups, site management support, health care management and the information and communication section could be continued in the scientific association “Kompetenznetz maligne Lymphome e.V.” which was founded in 2005.
Due to the recent in-depth understanding of the molecular and genetic mechanisms of lymphomagenesis and the consequent transformation to precision medicine targeting specialised groups of patients, the KML is currently facing the challenge of developing modern study, health-care and information concepts in ever shorter periods of time. Outstanding aim of the KMLis to combine available expertise and to rapidly transfer it into patient care. Current information on malignant lymphomas and on clinical trials is promptly prepared and provided for both health care professionals and patients.
For further information or support, please contact:
Competence Network Malignant Lymphomas (KML)
University Hospital of Cologne
Phone: +49 (0)221 478-96000
Fax: +49 (0)221 478-96001